A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
18h agoen
From the article
Conditions : Gastric Cancer; Oesophageal Carcinoma Interventions : Drug: SAR445877 Sponsors : Sanofi Not yet recruiting
Continue reading on clinicaltrials.gov
Comments
Sign in to join the conversation.
No comments yet. Be the first.